Fate Therapeutics, Inc. (FATE)

Fate Therapeutics, Inc. (FATE) is a healthcare company (biotechnology) based in the United States. The share price is $1.04, down 8.66% on the day, which values the company at $126.7M. Price as of 17 Nov 2026, 17:26 UTC, from Yahoo Finance.

Key facts

Share price
$1.04−8.66% today
Market value
$126.7M
Funk Score
25/100
Against its own history
Well below its usual priceusual price $1.75
200-week average
$2.8664% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Fate Therapeutics, Inc. in more detail

FATE trades at -1.1× next year's expected earnings, 26.7× sales. Measured against its own history, the price is 41% below what its usual multiples would imply ($1.75) — well below its usual price. It sits 64% below its 200-week average of $2.86.

Over the last five fiscal years Fate Therapeutics, Inc. has compounded revenue -26.7% a year. Its Funk Score is 25 out of 100 (financial strength 3.8, profitability 0.0, growth 1.3, value 5.0, each out of 10).

In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Weak Piotroski score.

Fate Therapeutics, Inc. (FATE): questions and answers

What is Fate Therapeutics, Inc.'s market cap?

Fate Therapeutics, Inc. is valued at $126.7M at a share price of $1.04.

Is FATE overvalued or undervalued?

Against its own history, FATE is well below its usual price: the price is 41% below the $1.75 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is FATE above its 200-week moving average?

No. FATE is 63.5% below its 200-week average of $2.86. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Fate Therapeutics, Inc. growing?

Over the last five fiscal years Fate Therapeutics, Inc.'s revenue grew -26.7% a year; over ten years revenue grew 10.6% a year.

Does FATE pay a dividend?

Fate Therapeutics, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Fate Therapeutics, Inc. (FATE) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/FATE

Underlying data: Yahoo Finance; company filings with the SEC.